Phase I/II clinical trial - Recherches "plusieurs pathologies"
REGOMUNE
Recherches "plusieurs pathologies"
Ouvert depuis le: 04.23.2024
Site: Saint-Cloud
Public cible
Adulte
A Phase I/II Study of Regorafenib Plus Avelumab in Solid Tumors
Description de l'essai
Assessment of the efficacy and safety of Regorafenib and Avelumab in patients with advanced or metastatic solid tumors (ten cohorts), once the Recommanded Phase II Dose (RP2D) has been determined (phase I trial).
Liens utiles
SEGOLENE HESCOT
Investigateur principal